201 related articles for article (PubMed ID: 34047251)
21. Medulloblastoma: molecular genetics and animal models.
Raffel C
Neoplasia; 2004; 6(4):310-22. PubMed ID: 15256053
[TBL] [Abstract][Full Text] [Related]
22. Challenges and Recent Advances in Medulloblastoma Therapy.
Kumar V; Kumar V; McGuire T; Coulter DW; Sharp JG; Mahato RI
Trends Pharmacol Sci; 2017 Dec; 38(12):1061-1084. PubMed ID: 29061299
[TBL] [Abstract][Full Text] [Related]
23. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
24. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
25. Multidisciplinary Management of Medulloblastoma: Consensus, Challenges, and Controversies.
Chatterjee A; Maitre M; Dasgupta A; Sridhar E; Gupta T
Methods Mol Biol; 2022; 2423():215-235. PubMed ID: 34978701
[TBL] [Abstract][Full Text] [Related]
26. Shedding light on adult medulloblastoma: current management and opportunities for advances.
Brandes AA; Franceschi E
Am Soc Clin Oncol Educ Book; 2014; ():e82-7. PubMed ID: 24857151
[TBL] [Abstract][Full Text] [Related]
27. Adult medulloblastoma, from spongioblastoma cerebelli to the present day: a review of treatment and the integration of molecular markers.
Shonka N; Brandes A; De Groot JF
Oncology (Williston Park); 2012 Nov; 26(11):1083-91. PubMed ID: 23330353
[TBL] [Abstract][Full Text] [Related]
28. [Medulloblastoma. Pathology].
Siegfried A; Delisle MB
Neurochirurgie; 2021 Feb; 67(1):28-38. PubMed ID: 29703584
[TBL] [Abstract][Full Text] [Related]
29. Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time.
Holgado BL; Guerreiro Stucklin A; Garzia L; Daniels C; Taylor MD
Annu Rev Genomics Hum Genet; 2017 Aug; 18():143-166. PubMed ID: 28475368
[TBL] [Abstract][Full Text] [Related]
30. The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second-generation subtypes.
Hicks D; Rafiee G; Schwalbe EC; Howell CI; Lindsey JC; Hill RM; Smith AJ; Adidharma P; Steel C; Richardson S; Pease L; Danilenko M; Crosier S; Joshi A; Wharton SB; Jacques TS; Pizer B; Michalski A; Williamson D; Bailey S; Clifford SC
Neuropathol Appl Neurobiol; 2021 Feb; 47(2):236-250. PubMed ID: 32779246
[TBL] [Abstract][Full Text] [Related]
31. Dissecting the genomic complexity underlying medulloblastoma.
Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
[TBL] [Abstract][Full Text] [Related]
32. Rethinking medulloblastoma from a targeted therapeutics perspective.
Hashimoto Y; Penas-Prado M; Zhou S; Wei J; Khatua S; Hodges TR; Sanai N; Xiu J; Gatalica Z; Kim L; Kesari S; Rao G; Spetzler D; Heimberger A
J Neurooncol; 2018 Sep; 139(3):713-720. PubMed ID: 29869738
[TBL] [Abstract][Full Text] [Related]
33. Medulloblastoma stem cells: modeling tumor heterogeneity.
Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK
Cancer Lett; 2013 Sep; 338(1):23-31. PubMed ID: 22796365
[TBL] [Abstract][Full Text] [Related]
34. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.
Sutter R; Shakhova O; Bhagat H; Behesti H; Sutter C; Penkar S; Santuccione A; Bernays R; Heppner FL; Schüller U; Grotzer M; Moch H; Schraml P; Marino S
Oncogene; 2010 Mar; 29(12):1845-56. PubMed ID: 20062081
[TBL] [Abstract][Full Text] [Related]
35. Emerging treatments and gene expression profiling in high-risk medulloblastoma.
Sardi I; Cavalieri D; Massimino M
Paediatr Drugs; 2007; 9(2):81-96. PubMed ID: 17407364
[TBL] [Abstract][Full Text] [Related]
36. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity and tumoral origin of medulloblastoma in the single-cell era.
Sheng H; Li H; Zeng H; Zhang B; Lu Y; Liu X; Xu Z; Zhang J; Zhang L
Oncogene; 2024 Mar; 43(12):839-850. PubMed ID: 38355808
[TBL] [Abstract][Full Text] [Related]
38. Medulloblastoma: mouse models and novel targeted therapies based on the Sonic hedgehog pathway.
Piedimonte LR; Wailes IK; Weiner HL
Neurosurg Focus; 2005 Nov; 19(5):E8. PubMed ID: 16398472
[TBL] [Abstract][Full Text] [Related]
39. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
Kumar R; Smith KS; Deng M; Terhune C; Robinson GW; Orr BA; Liu APY; Lin T; Billups CA; Chintagumpala M; Bowers DC; Hassall TE; Hansford JR; Khuong-Quang DA; Crawford JR; Bendel AE; Gururangan S; Schroeder K; Bouffet E; Bartels U; Fisher MJ; Cohn R; Partap S; Kellie SJ; McCowage G; Paulino AC; Rutkowski S; Fleischhack G; Dhall G; Klesse LJ; Leary S; Nazarian J; Kool M; Wesseling P; Ryzhova M; Zheludkova O; Golanov AV; McLendon RE; Packer RJ; Dunham C; Hukin J; Fouladi M; Faria CC; Pimentel J; Walter AW; Jabado N; Cho YJ; Perreault S; Croul SE; Zapotocky M; Hawkins C; Tabori U; Taylor MD; Pfister SM; Klimo P; Boop FA; Ellison DW; Merchant TE; Onar-Thomas A; Korshunov A; Jones DTW; Gajjar A; Ramaswamy V; Northcott PA
J Clin Oncol; 2021 Mar; 39(7):807-821. PubMed ID: 33502920
[TBL] [Abstract][Full Text] [Related]
40. Childhood medulloblastoma: current status of biology and treatment.
Klesse LJ; Bowers DC
CNS Drugs; 2010 Apr; 24(4):285-301. PubMed ID: 20297854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
